Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage

ανά Fukuda, Ryo, Sugawara, Shunichi, Kondo, Yasuteru
Τόπος έκδοσης Intern Med (2020)

Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring

ανά Katsume, Yumi, Isawa, Tsuyoshi, Toi, Yukihiro, Fukuda, Ryo, Kondo, Yasuteru, Sugawara, Shunichi, Ootomo, Tatsushi
Τόπος έκδοσης Intern Med (2018)

Prospective Multicenter Study of Chemotherapy-Induced Clostridium (Clostridioides) difficile Infection in Patients With Lung Cancer: North Japan Lung Cancer Study Group Trial 1204

ανά Toi, Yukihiro, Kobayashi, Takao, Harada, Toshiyuki, Nakagawa, Taku, Mori, Yoshiaki, Kuda, Tomoya, Sugawara, Shunichi
Τόπος έκδοσης Front Oncol (2021)

Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination

ανά Waki, Kayoko, Yamada, Teppei, Yoshiyama, Koichi, Terazaki, Yasuhiro, Sakamoto, Shinjiro, Sugawara, Shunichi, Takamori, Shinzo, Itoh, Kyogo, Yamada, Akira
Τόπος έκδοσης Oncol Lett (2017)

Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma

ανά Kawana, Sachiko, Saito, Ryoko, Miki, Yasuhiro, Kimura, Yuichiro, Abe, Jiro, Sato, Ikuro, Endo, Mareyuki, Sugawara, Shunichi, Sasano, Hironobu
Τόπος έκδοσης Cancer Med (2020)

Phase II Study of Low‐Dose Afatinib Maintenance Treatment Among Patients with EGFR‐Mutated Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601)...

ανά Nakamura, Atsushi, Tanaka, Hisashi, Saito, Ryota, Suzuki, Aya, Harada, Toshiyuki, Inoue, Sumito, Yamada, Toru, Nakagawa, Taku, Jingu, Daisuke, Sugawara, Shunichi
Τόπος έκδοσης Oncologist (2020)

A Remarkable Clinical Response to Pembrolizumab in a Rare Spindle Cell Carcinoma of the Lung

ανά Tsurumi, Kyoji, Kawashima, Yosuke, Akahira, Junichi, Saito, Ryohei, Toi, Yukihiro, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro, Sugawara, Shunichi
Τόπος έκδοσης JMA J (2019)

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study

ανά Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki
Τόπος έκδοσης Cancer Sci (2021)

PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer

ανά Waki, Kayoko, Yamada, Teppei, Yoshiyama, Koichi, Terazaki, Yasuhiro, Sakamoto, Shinjiro, Matsueda, Satoko, Komatsu, Nobukazu, Sugawara, Shunichi, Takamori, Shinzo, Itoh, Kyogo, Yamada, Akira
Τόπος έκδοσης Cancer Sci (2014)

Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q

ανά Watanabe, Satoshi, Minegishi, Yuji, Yoshizawa, Hirohisa, Maemondo, Makoto, Inoue, Akira, Sugawara, Shunichi, Isobe, Hiroshi, Harada, Masao, Ishii, Yoshiki, Gemma, Akihiko, Hagiwara, Koichi, Kobayashi, Kunihiko
Έκδοση 2014

A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

ανά Minegishi, Yuji, Yamaguchi, Ou, Sugawara, Shunichi, Kuyama, Shoichi, Watanabe, Satoshi, Usui, Kazuhiro, Mori, Masahide, Hataji, Osamu, Nukiwa, Toshihiro, Morita, Satoshi, Kobayashi, Kunihiko, Gemma, Akihiko
Τόπος έκδοσης BMC Cancer (2021)

Phase II Study of Modified Carboplatin Plus Weekly Nab‐Paclitaxel in Elderly Patients with Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301

ανά Miyauchi, Eisaku, Inoue, Akira, Usui, Kazuhiro, Sugawara, Shunichi, Maemondo, Makoto, Saito, Heisuke, Fujita, Yuka, Kato, Terufumi, Suzuki, Toshiro, Harada, Toshiyuki, Watanabe, Hiroshi, Nakagawa, Taku, Ichinose, Masakazu
Τόπος έκδοσης Oncologist (2017)

Multicenter, placebo‐controlled, double‐blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy‐induced nausea and vomiting in...

ανά Sugawara, Shunichi, Inui, Naoki, Kanehara, Masashi, Morise, Masahiro, Yoshimori, Kozo, Kumagai, Toru, Fukui, Tomoya, Minato, Koichi, Iwashima, Akira, Takeda, Yuichiro, Kubota, Kaoru, Saeki, Toshiaki, Tamura, Tomohide
Τόπος έκδοσης Cancer (2019)

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset

ανά Ohe, Yuichiro, Imamura, Fumio, Nogami, Naoyuki, Okamoto, Isamu, Kurata, Takayasu, Kato, Terufumi, Sugawara, Shunichi, Ramalingam, Suresh S, Uchida, Hirohiko, Hodge, Rachel, Vowler, Sarah L, Walding, Andrew, Nakagawa, Kazuhiko
Τόπος έκδοσης Jpn J Clin Oncol (2018)

Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Ce...

ανά Takayama, Koichi, Sugawara, Shunichi, Saijo, Yasuo, Maemondo, Makoto, Sato, Atsushi, Takamori, Shinzo, Harada, Taishi, Sasada, Tetsuro, Kakuma, Tatsuyuki, Kishimoto, Junji, Yamada, Akira, Noguchi, Masanori, Itoh, Kyogo, Nakanishi, Yoichi
Τόπος έκδοσης J Immunol Res (2016)

EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation

ανά Yamada, Teppei, Azuma, Koichi, Muta, Emi, Kim, Jintaek, Sugawara, Shunichi, Zhang, Guang Lan, Matsueda, Satoko, Kasama-Kawaguchi, Yuri, Yamashita, Yuichi, Yamashita, Takuto, Nishio, Kazuto, Itoh, Kyogo, Hoshino, Tomoaki, Sasada, Tetsuro
Έκδοση 2013

Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Gro...

ανά Maemondo, Makoto, Inoue, Akira, Sugawara, Shunichi, Harada, Toshiyuki, Minegishi, Yuji, Usui, Kazuhiro, Miwa, Koji, Morikawa, Naoto, Kambe, Mariko, Ube, Kenji, Watanabe, Kana, Ishimoto, Osamu, Sakakibara, Tomohiro, Gemma, Akihiko, Nukiwa, Toshihiro
Έκδοση 2014

Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab

ανά Toi, Yukihiro, Sugawara, Shunichi, Kawashima, Yosuke, Aiba, Tomoiki, Kawana, Sachiko, Saito, Ryohei, Tsurumi, Kyoji, Suzuki, Kana, Shimizu, Hisashi, Sugisaka, Jun, Ono, Hirotaka, Domeki, Yutaka, Terayama, Keisuke, Nakamura, Atsushi, Yamanda, Shinsuke, Kimura, Yuichiro, Honda, Yoshihiro
Τόπος έκδοσης Oncologist (2018)

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma

ανά Inoue, Daisuke, Suzuki, Takashi, Mitsuishi, Yoichiro, Miki, Yasuhiro, Suzuki, Satoshi, Sugawara, Shunichi, Watanabe, Mika, Sakurada, Akira, Endo, Chiaki, Uruno, Akira, Sasano, Hironobu, Nakagawa, Takayuki, Satoh, Kennichi, Tanaka, Nobuyuki, Kubo, Hiroshi, Motohashi, Hozumi, Yamamoto, Masayuki
Τόπος έκδοσης Cancer Sci (2012)

A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901

ανά Harada, Toshiyuki, Oizumi, Satoshi, Ito, Kenichiro, Takamura, Kei, Kikuchi, Eiki, Kuda, Tomoya, Sugawara, Shunichi, Suzuki, Aya, Maemondo, Makoto, Fujita, Yuka, Kinoshita, Ichiro, Inoue, Akira, Hommura, Fumihiro, Katsuura, Yutaka, Dosaka-Akita, Hirotoshi, Isobe, Hiroshi, Nishimura, Masaharu
Έκδοση 2013